Ody C M Sibon (Ody Cm Sibon)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 4

Top Venues

EMBO molecular medicine

eLife

Development (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Anita I E Faber, Marianne van der Zwaag, Hein Schepers, Ellie Eggens-Meijer, Bart Kanon, Carmen IJsebaart, Jeroen Kuipers, Ben N G Giepmans, Raimundo Freire, Nicola A Grzeschik, Catherine Rabouille, Ody C M Sibon
Vps13 is required for timely removal of nurse cell corpses. Development (Cambridge, England) 147 (20) (2020)
Wondwossen M Yeshaw, Marianne van der Zwaag, Francesco Pinto, Liza L Lahaye, Anita Ie Faber, Rubén Gómez-Sánchez, Amalia M Dolga, Conor Poland, Anthony P Monaco, Sven Cd van IJzendoorn, Nicola A Grzeschik, Antonio Velayos-Baeza, Ody C M Sibon
Human VPS13A is associated with multiple organelles and influences mitochondrial morphology and lipid droplet motility. eLife 8 (2019)
Suh Young Jeong, Penelope Hogarth, Andrew Placzek, Allison M Gregory, Rachel Fox, Dolly Zhen, Jeffrey Hamada, Marianne van der Zwaag, Roald Lambrechts, Haihong Jin, Aaron Nilsen, Jared Cobb, Thao Pham, Nora Gray, Martina Ralle, Megan Duffy, Leila Schwanemann, Puneet Rai, Alison Freed, Katrina Wakeman, Randall L Woltjer, Ody C M Sibon, Susan J Hayflick
4'-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN. EMBO molecular medicine 11 (12) (2019)
Roald A Lambrechts, Hein Schepers, Yi Yu, Marianne van der Zwaag, Kaija J Autio, Marcel A Vieira-Lara, Barbara M Bakker, Marina A Tijssen, Susan J Hayflick, Nicola A Grzeschik, Ody C M Sibon
CoA-dependent activation of mitochondrial acyl carrier protein links four neurodegenerative diseases. EMBO molecular medicine 11 (12) (2019)

Ody C M Sibon.css-eqlu8i{font-size:small;padding-left:4px;} (Ody Cm Sibon)

Publication Activity (10 Years)

Top Topics

Top Venues

Ody C M Sibon (Ody Cm Sibon)